Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Health
Grant: CA100632
National Institute of Health
Grant: CA055164
Cancer Prevention and Research Institute of Texas
Grant: RP121010
National Institute of Health
Grant: CA016672
National Institutes of Health
Grant: 3P50CA100632-06S1
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
National Institutes of Health
Grant: 5P01CA055164-13
THERAPY OF AML
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
Additional file 1 of An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer